PostTraumatic Stress Disorder Clinical Trial
Official title:
Co-occurring Eating Disorders and Posttraumatic Stress Disorder: Facilitating Full and Sustained Recovery Through Empirically-Based Concurrent Treatment
Although psychotherapy for eating disorders (EDs) can be effective, approximately 50% of
those who complete a course of the best available therapy continue to have significant ED
symptoms at the end of treatment. Posttraumatic stress disorder (PTSD) commonly co-occurs
with EDs and is thought to be one reason why some individuals do not remit from their ED with
best available treatment or relapse following treatment. In particular, ED behaviours can
function as coping methods for PTSD symptoms, and thus interfere with successful and lasting
ED recovery. The main objective of this initial treatment trial is to determine whether a
concurrent treatment approach, in which PTSD symptoms are treated at the same time as ED
symptoms, provides an advantage over standard ED treatment by successfully alleviating PTSD
symptoms.
Forty participants who have both an ED and PTSD will be assigned to receive either (1)
standard ED psychotherapy alone or (2) standard ED psychotherapy concurrent with PTSD
psychotherapy. After treatment, participants will be followed for a period of 6 months to
determine whether improvements made during therapy are maintained after treatment. ED and
PTSD symptoms, as well as concomitant symptoms (e.g., anxiety and depression) will be
assessed immediately before and after treatment, as well as 3 and 6 months after treatment.
Standard ED treatment is characterized by partial response in many individuals, and the risk
of relapse is high. This, in combination with significant rates of comorbid PTSD, evidence
that trauma history can negatively impact ED treatment outcome, and the observation that PTSD
may be a central ED maintaining factor in these individuals, has led us to develop a program
of research aimed at demonstrating that the alleviation of PTSD symptoms concurrent with ED
treatment facilitates a fuller and sustained ED recovery for these individuals.
The specific aims of this initial randomized controlled trial (RCT) are to determine: (1) the
immediate and short-term efficacy of concurrent evidence-based ED and PTSD treatment in
reducing PTSD symptoms relative to standard ED treatment; and (2) estimates of the effect
sizes of concurrent treatment on ED symptomatology relative to standard ED treatment at
post-treatment and follow-up.
Primary Hypothesis:
1. Concurrent CBT for ED and PTSD will result in significantly greater improvements in
clinician-rated PTSD symptoms at post-treatment, as well as at 3- and 6-month follow-up
compared with CBT for ED alone.
Secondary Hypotheses:
2. Concurrent CBT for ED and PTSD will result in significantly greater improvements in
self-reported PTSD symptoms at post-treatment, as well as at 3- and 6-month follow-up
compared with CBT for ED alone.
3. Concurrent CBT for ED and PTSD will result in significantly greater improvements in
concomitant symptoms (e.g., anxiety and depression) at post-treatment, as well as at 3-
and 6-month follow-up compared with CBT for ED alone.
Exploratory Research Questions
1. What proportion of participants experience reliable improvement in ED symptomatology and
what proportion experience reliable deterioration in ED symptomatology over the course
of each treatment?
2. What is the relative efficacy of concurrent CBT for ED and PTSD versus CBT for ED alone
in reducing functional deficits at post-treatment, and 3- and 6-month follow-up?
3. What is the relative efficacy of concurrent CBT for ED and PTSD versus CBT for ED alone
in improving other concomitant symptoms at post-treatment, and 3- and 6-month follow-up?
METHOD:
Following a course of intensive ED treatment in the inpatient or day hospital ED program at
University Health Network (UHN), participants will be randomly assigned to receive either
individually-administered: (1) standard CBT for ED alone or (2) concurrent CBT for ED and
PTSD. Participants in both conditions will receive 16 sessions. Eleven of the 16 concurrent
CBT for ED and PTSD sessions will be 90 minutes long in order to accommodate the
administration of CBT for ED and PTSD. Participants in the CBT for ED alone condition will
also receive eleven 90-minute sessions in order to control for time in therapy. In the CBT
for ED condition, therapists will have more time to cover the ED-related content.
Accordingly, both treatments will consist of eleven 90-minute sessions and five 50-minute
sessions, with two sessions per week for the first 8 sessions, weekly sessions for the
following 6 sessions, and biweekly for the final two sessions.
Participants will be assessed pre-CBT for ED/PTSD and post-CBT for ED/PTSD, as well as 3 and
6 months after treatment. The assessors will be blind to treatment condition, and an
intent-to-treat (ITT) approach to data collection and analysis will be adopted. ED and PTSD
symptoms will also be assessed on a weekly basis during the study treatments.
STATISTICS:
1. Primary hypothesis: Changes in clinician-rated PTSD symptoms will be analyzed using
multilevel modeling, including a random effect for time and fixed effects for therapy
condition, time, and the condition by time interaction. Change in PTSD symptoms over
time and differences between the conditions over time will be examined. Empirically
derived covariates that significantly reduce error variance will be used. Cohen's d
effect sizes will be calculated.
2. Secondary hypotheses: Changes in self-reported PTSD symptoms, anxiety, and depresion
will be analyzed using multilevel modeling, including a random effect for time and fixed
effects for therapy condition, time, and the condition by time interaction. Change in
PTSD symptoms, anxiety, and depression over time and differences between the conditions
over time will be examined. Empirically derived covariates that significantly reduce
error variance will be used. Cohen's d effect sizes will be calculated.
3. The proportion of participants who experience reliable improvement and the proportion
who experience reliable deterioration in ED symptomatology in each therapy condition
will be calculated using reliable change criteria (Jacobson & Truax, 1991).
4. The proportion of participants meeting diagnostic criteria for PTSD and an eating
disorder will be compared between conditions at post-treatment and follow-up.
5. Changes in other concomitant symptoms and functional deficits will be analyzed using
multilevel modeling as described above.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03384706 -
A Comparison of CPT Versus ART Versus WL
|
N/A | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03129204 -
Sensation Awareness Focused Training for Spouses
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Completed |
NCT05113277 -
Development and Evaluation of a Tonic Immobility Focused Psychoeducational Intervention
|
N/A | |
Recruiting |
NCT05327504 -
Written Exposure Therapy for Veterans With SUD and PTSD
|
N/A | |
Recruiting |
NCT05843695 -
Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety
|
N/A | |
Active, not recruiting |
NCT05530642 -
An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel
|
N/A | |
Completed |
NCT00644423 -
Omega-3 Fatty Acids and Post Traumatic Stress Disorder (PTSD)
|
N/A | |
Completed |
NCT02989987 -
NET for SGBV Survivors in Eastern DR Congo
|
N/A | |
Completed |
NCT02320799 -
Randomized Controlled Trial of Interpersonal Psychotherapy for Depression and PTSD Among HIV+ Women in Kenya
|
N/A | |
Recruiting |
NCT02293291 -
Thermal Clinic Treatment in Gulf War Illness
|
Phase 1/Phase 2 | |
Completed |
NCT02242136 -
Treatment of Posttraumatic Stress Disorder and Aggressive Behavior in Soldiers and Ex-combatants
|
N/A | |
Completed |
NCT01911585 -
Efficacy of 60-minute Versus 90-minute Sessions in Treating PTSD Using Prolonged Exposure
|
N/A | |
Completed |
NCT02720497 -
The Efficacy of 90-Minute Versus 60-Minute Sessions of Prolonged Exposure for PTSD
|
N/A | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Completed |
NCT01693978 -
Contingency Outcomes in Prolonged Exposure
|
N/A | |
Completed |
NCT01469754 -
Longitudinal Survey Analysis in Lymphoma Survivors
|
N/A | |
Completed |
NCT02362477 -
Telemental Health and Cognitive Processing Therapy for Female Veterans With Military-related PTSD
|
Phase 3 | |
Terminated |
NCT01239173 -
Emotional Memory Reactivation in Posttraumatic Stress Disorder
|
Phase 3 |